clinical trial diversity

rare disease trials patient support services

BioProcess International eBook: Patient Support for Rare Disease Trials

Download the eBook today! By providing direct support to participants from enrollment through the end of a clinical trial, logistics-management companies can help ease the financial, logistical, and psychological barriers to patient participation in rare disease trials. Such dedicated services can build trust between participants or caregivers and patient coordinators, improving the overall trial experience […]

BioProcess International eBook: Patient Support for Rare Disease Trials Read More »

CISCRP patient diversity inclusion equity

CISCRP: Supporting Patient Diversity Campaign Fall 2021

Clincierge is proud to support CISCRP in a new educational initiative to increase awareness about clinical research and the level of understanding among minority communities across the U.S.We have united to circulate an informative full-page advertorial spread highlighting the key importance of diversity in clinical studies to discover treatments that are effective for everyone.

CISCRP: Supporting Patient Diversity Campaign Fall 2021 Read More »

national diversity month patient diversity rare disease

Global Diversity Month: Improving Awareness, Patient Diversity, and Access in Rare Disease Clinical Trials

Members of ethnic communities around the globe suffer from rare diseases unique to their demographic group. Designing a trial and selecting participants with diverse backgrounds that proportionally represent each demographic group is one of the first steps a sponsor can take to create a diverse and inclusive clinical trial.

Global Diversity Month: Improving Awareness, Patient Diversity, and Access in Rare Disease Clinical Trials Read More »

decentralized clinical trial hybrid clinical trial

COVID-19 and the Changing Landscape of Clinical Trials

 Featured in Applied Clinical Trials: Decentralized trials are the way of the future—yet it would be ill-advised to think of them as a one-size-fits-all solution. While the pandemic increased the industry’s acceptance of decentralized clinical trial protocols, moving to an entirely virtual model without in-person interaction is unrealistic. This sort of hybrid approach allows researchers

COVID-19 and the Changing Landscape of Clinical Trials Read More »

Alzheimer's patient looking

Clinical Matters: Recruiting and Retaining Alzheimer’s Patients for Clinical Trials

With a greater understanding of the challenges facing patients, caregivers, and physicians, researchers can better structure Alzheimer’s disease studies to minimize barriers and improve participation. By providing direct support to participants from enrollment through the end of a clinical trial, logistics management companies establish and maintain a sense of trust between participants, caregivers, and site

Clinical Matters: Recruiting and Retaining Alzheimer’s Patients for Clinical Trials Read More »

Patient Diversity in O&P trials

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients

Achieving Diversity in Orthotic and Prosthetic Clinical Trials Logistical and financial barriers have created significant barriers to clinical trial participation, resulting in historical under-representation of minority populations in clinical trials. As the industry seeks to counter past shortcomings, sponsors in the O&P space must utilize proactive strategies to recruit diverse populations to ensure appropriate diversity.

Achieving Diversity in O&P Clinical Trials: The Role of Support Services in Recruiting and Retaining O&P Patients Read More »

Clinical trial diversity

Achieving Clinical Trial Diversity Through Actionable Steps

The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and

Achieving Clinical Trial Diversity Through Actionable Steps Read More »

error: Protected content.